2022
DOI: 10.1002/slct.202201559
|View full text |Cite
|
Sign up to set email alerts
|

Benzimidazole‐1,3,4‐Oxadiazole Hybrids: Synthesis, Anticancer Evaluation, Docking and DFT Studies

Abstract: In the present work, new benzimidazole based 1,3,4-oxadiazole linked thioacetamide conjugates have been synthesized and evaluated for antiproliferative activity. Formation of all the target molecules were elucidated by NMR ( 1 H & 13 C), FTIR, mass spectrometry and other techniques. The compounds displayed significant to moderate cytotoxicity towards MCF-7, HepG2 and HCT-116 cancerous cell lines. Among all the compounds, compound 11, 12 and 13 showed promising cytotoxicity with IC 50 2.39-10.98 μM, 4.57-16.35 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 39 publications
0
5
0
Order By: Relevance
“…Compound 3 d showed the highest antioxidant activity in good agreement with the lower value of electronic chemical potential calculated (Table 1). [38] …”
Section: Resultsmentioning
confidence: 99%
“…Compound 3 d showed the highest antioxidant activity in good agreement with the lower value of electronic chemical potential calculated (Table 1). [38] …”
Section: Resultsmentioning
confidence: 99%
“…The indazole nucleus, distinguished by its five-membered heterocyclic structure, has become a focal point of interest owing to its remarkable spectrum of pharmacological activities, spanning anticancer, antioxidant and antimicrobial properties. [2,3] The allure of indazole lies in its capacity to open up new vistas in therapy, presenting the tantalizing prospect of pioneering medications that have the potential to revolutionize the healthcare landscape. Its ubiquitous presence in nature establishes indazole as a pivotal scaffold for numerous indispensable molecules in the realms of biology and medicine.…”
Section: Introductionmentioning
confidence: 99%
“…Among the myriad of compounds under scrutiny, indazole derivatives have emerged as a particularly compelling class, captivating substantial attention for their auspicious pharmacological applications. The indazole nucleus, distinguished by its five‐membered heterocyclic structure, has become a focal point of interest owing to its remarkable spectrum of pharmacological activities, spanning anticancer, antioxidant and antimicrobial properties [2,3] . The allure of indazole lies in its capacity to open up new vistas in therapy, presenting the tantalizing prospect of pioneering medications that have the potential to revolutionize the healthcare landscape.…”
Section: Introductionmentioning
confidence: 99%
“…[19,20] The broad and potent activity of 1,3,4-oxadiazole and their derivatives has established them as important pharmacological scaffolds, especially in the treatment of cancer disease. [21][22][23][24] For example, Zibotentan, an FDAapproved anticancer drug, is a 1,3,4-oxadiazole nucleus that contains the most exclusive derivatives on the market [20] Figure 1.…”
Section: Introductionmentioning
confidence: 99%
“…Figure 1 shows some drugs with 1,3,4‐oxadiazole scaffold, for example, Furamizole (a nitrofuran derivative with potent antibacterial activity), Nesapidil (vasodilator agent), Raltegravir (antiviral)and Tiodazosin (antihypertensive agent) [19,20] . The broad and potent activity of 1,3,4‐oxadiazole and their derivatives has established them as important pharmacological scaffolds, especially in the treatment of cancer disease [21–24] . For example, Zibotentan, an FDA‐approved anticancer drug, is a 1,3,4‐oxadiazole nucleus that contains the most exclusive derivatives on the market [20] Figure 1.…”
Section: Introductionmentioning
confidence: 99%